122 related articles for article (PubMed ID: 37165582)
21. Potential Protective Role of Rutin and Alpha-lipoic Acid Against Cisplatin-induced Nephrotoxicity in Rats.
Zaazaa AM; Motelp BAAE; Aniss NN
Pak J Biol Sci; 2019 Jan; 22(8):361-371. PubMed ID: 31930824
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of alpha-lipoic acid in attenuating kanamycin-induced ototoxicity.
Wang A; Hou N; Bao D; Liu S; Xu T
Neural Regen Res; 2012 Dec; 7(35):2793-800. PubMed ID: 25317129
[TBL] [Abstract][Full Text] [Related]
23. Effect of protective agents against cisplatin ototoxicity.
Rybak LP; Husain K; Morris C; Whitworth C; Somani S
Am J Otol; 2000 Jul; 21(4):513-20. PubMed ID: 10912697
[TBL] [Abstract][Full Text] [Related]
24. Effect of cisplatin on distortion product otoacoustic emissions in Japanese patients.
Eiamprapai P; Yamamoto N; Hiraumi H; Ogino-Nishimura E; Kitamura M; Hirano S; Ito J
Laryngoscope; 2012 Jun; 122(6):1392-6. PubMed ID: 22555987
[TBL] [Abstract][Full Text] [Related]
25. Levosimendan ameliorates cisplatin-induced ototoxicity: Rat model.
Gozeler MS; Ekinci Akdemir FN; Yildirim S; Sahin A; Eser G; Askin S
Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():70-75. PubMed ID: 30978472
[TBL] [Abstract][Full Text] [Related]
26. Distortion-product otoacoustic emission test performance for ototoxicity monitoring.
Reavis KM; McMillan G; Austin D; Gallun F; Fausti SA; Gordon JS; Helt WJ; Konrad-Martin D
Ear Hear; 2011 Feb; 32(1):61-74. PubMed ID: 20625302
[TBL] [Abstract][Full Text] [Related]
27. Protective roles of fenofibrate against cisplatin-induced ototoxicity by the rescue of peroxisomal and mitochondrial dysfunction.
Kim SJ; Park C; Lee JN; Park R
Toxicol Appl Pharmacol; 2018 Aug; 353():43-54. PubMed ID: 29908243
[TBL] [Abstract][Full Text] [Related]
28. Protective effect of thymoquinone against cisplatin-induced ototoxicity.
Sagit M; Korkmaz F; Akcadag A; Somdas MA
Eur Arch Otorhinolaryngol; 2013 Aug; 270(8):2231-7. PubMed ID: 23161274
[TBL] [Abstract][Full Text] [Related]
29. Dose dependent protection by lipoic acid against cisplatin-induced ototoxicity in rats: antioxidant defense system.
Rybak LP; Husain K; Whitworth C; Somani SM
Toxicol Sci; 1999 Feb; 47(2):195-202. PubMed ID: 10220857
[TBL] [Abstract][Full Text] [Related]
30. The radioprotective effects of alpha-lipoic acid on radiotherapy-induced toxicities: A systematic review.
Sheikholeslami S; Khodaverdian S; Dorri-Giv M; Mohammad Hosseini S; Souri S; Abedi-Firouzjah R; Zamani H; Dastranj L; Farhood B
Int Immunopharmacol; 2021 Jul; 96():107741. PubMed ID: 33989970
[TBL] [Abstract][Full Text] [Related]
31. The Protective Effect of Cortexin on Cisplatin-Induced Ototoxicity.
Eroğlu O; Karlıdağ T; Kuloğlu T; Keleş E; Kaygusuz İ; Yalçın Ş
J Int Adv Otol; 2018 Apr; 14(1):27-33. PubMed ID: 29092803
[TBL] [Abstract][Full Text] [Related]
32. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
[TBL] [Abstract][Full Text] [Related]
33. The effectiveness of eugenol against cisplatin-induced ototoxicity.
Sakat MS; Kilic K; Akdemir FNE; Yildirim S; Eser G; Kiziltunc A
Braz J Otorhinolaryngol; 2019; 85(6):766-773. PubMed ID: 30126770
[TBL] [Abstract][Full Text] [Related]
34. Cisplatin ototoxicity in developing gerbils.
Tampakopoulou DA; Sie KC
Hear Res; 1999 Jun; 132(1-2):51-9. PubMed ID: 10392547
[TBL] [Abstract][Full Text] [Related]
35. Intraperitoneal curcumin and vitamin E combination for the treatment of cisplatin-induced ototoxicity in rats.
Soyalıç H; Gevrek F; Koç S; Avcu M; Metin M; Aladağ İ
Int J Pediatr Otorhinolaryngol; 2016 Oct; 89():173-8. PubMed ID: 27619052
[TBL] [Abstract][Full Text] [Related]
36. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
37. The protective effect of astaxanthin on cisplatin-induced ototoxicity.
Terzi S; Özgür A; Çeliker M; Mercantepe T; Yilmaz A; Tümkaya L; Kaya Ş; Demir E; Dursun E
Adv Clin Exp Med; 2021 Mar; 30(3):315-321. PubMed ID: 33789004
[TBL] [Abstract][Full Text] [Related]
38. ABR obtained from time-efficient train stimuli for cisplatin ototoxicity monitoring.
Dille MF; Ellingson RM; McMillan GP; Konrad-Martin D
J Am Acad Audiol; 2013 Oct; 24(9):769-81. PubMed ID: 24224985
[TBL] [Abstract][Full Text] [Related]
39. Protection against cisplatin-induced ototoxicity by adeno-associated virus-mediated delivery of the X-linked inhibitor of apoptosis protein is not dependent on caspase inhibition.
Chan DK; Lieberman DM; Musatov S; Goldfein JA; Selesnick SH; Kaplitt MG
Otol Neurotol; 2007 Apr; 28(3):417-25. PubMed ID: 17211286
[TBL] [Abstract][Full Text] [Related]
40. Baseline audiological profiling of South African females with cervical cancer: an important attribute for assessing cisplatin-associated ototoxicity.
Paken J; Govender CD; Pillay M; Ayele BT; Sewram V
BMC Womens Health; 2021 Apr; 21(1):164. PubMed ID: 33879158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
